Home / IO Best Practices / Continuing Education Credits

Continuing Education Credits

Best Practices for Implementing Cancer Immunotherapy in the Community

Objectives:

  • Evaluate practical issues related to immuno-oncology and devise strategies to overcome the barriers to providing optimal patient care in the community setting
  • Assess alignment of current practice with best practices related to coordination and communication within the multidisciplinary cancer care team to optimize integration of cancer immunotherapies
  • Examine solutions to coverage and reimbursement issues associated with implementation of immunotherapies in the community setting
  • Discuss strategies to engage patients to actively participate in the shared decision-making process

Accreditation Statement

Jointly Accredited Provider LogoIn support of improving patient care, this activity has been planned and implemented by AXIS Medical Education and The Association of Community Cancer Centers (ACCC).  AXIS Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation for Physicians
AXIS Medical Education designates this live activity for a maximum of 4.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit Designation for Pharmacists
This application-based activity is approved for 4.0 contact hours of continuing pharmacy education credit.

Credit Designation for Nursing
AXIS Medical Education designates this continuing nursing education activity for 4.0 contact hours.

Learners are advised that accredited status does not imply endorsement by the provider or ANCC of any commercial products displayed in conjunction with an activity.

AXIS Contact Information
For information about the accreditation of this program please contact AXIS at info@axismeded.org.

Disclosure of Conflicts of Interest
AXIS Medical Education requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by AXIS for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

The faculty reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity:

 

Name of Faculty or Presenter Reported Financial Relationship
   
Missak Haigentz, Jr., MD Advisory Board: AstraZeneca
Ari VanderWalde, MD, MPH, FACP   Research grant: Amgen; Advisory Board: Bristol Myers Squibb and Genentech
Laura Wood, RN, MSN, OCN  Consultant: Merck; Speakers bureau for Bristol Myers Squibb and Pfizer 
Irene Costello, RN, BSN  Nothing to disclose 

The planners and managers reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity:

Name of Planner / Manager / Reviewer / Advisor Reported Financial Relationship
   
Missak Haigentz, Jr., MD Advisory Board: AstraZeneca
Ari VanderWalde, MD, MPH, FACP   Research grant: Amgen; Advisory Board: Bristol Myers Squibb and Genentech
Laura Wood, RN, MSN, OCN  Consultant: Merck; Speakers bureau for Bristol Myers Squibb and Pfizer 
Latha Shivakumar, PhD  Nothing to disclose 
Tara Perloff Nothing to disclose 
Lorna Lucas, MSM Nothing to disclose 
Linda Graci-King, MS  Nothing to disclose 
Stephanie Sutphin, PharmD  Nothing to disclose 
Dee Morgillo, MEd., CHCP  Nothing to disclose

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Safeguards Against Commercial Bias

AXIS Medical Education affirms that the content and format of the certified activity and its related materials promote improvements and quality in healthcare and do not promote a specific proprietary business interest of a commercial entity. To this end, AXIS employs several strategies to ensure the absence of commercial bias, including, but not limited to, review of all planned content for certified activities to ensure adherence to the Accreditation Council for Continuing Medical Education’s content validation guidelines, and resolution of any actual or perceived conflicts of interest that exist.

We employ several metrics during review of content materials, including:

  1. Fair balance
    • Recommendations must be based on a reasonable and valid interpretation of the information available on the subject matter
    • No single product or service is overrepresented when other equal, competing products or services are available for inclusion
  2. Scientific objectivity of studies mentioned in the activity or used as the basis for content development

Fee Information
There is no fee for this educational activity.

Method of Participation and Request for Credit
To receive credit for this activity, participants must review the activity information including learning objectives and faculty/planner disclosures and actively participate in the educational activity. Upon successfully completing the post-test with a score of 75% or better and the post-activity evaluation, your certificate will be emailed to you. For pharmacists, your record will be uploaded to CPE Monitor.

Our Partner

AXIS Medical Education Logo

Supporter

This activity is supported by an educational grant from the Bristol-Myers Squibb Company.